Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $42.37 in the prior trading day, Genpact Ltd (NYSE: G) closed at $42.2, down -0.40%. In other words, the price has decreased by -$0.40 from its previous closing price. On the day, 2.76 million shares were traded. G stock price reached its highest trading level at $42.67 during the session, while it also had its lowest trading level at $41.765.
Ratios:
Our goal is to gain a better understanding of G by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.14 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.29. For the most recent quarter (mrq), Quick Ratio is recorded 2.45 and its Current Ratio is at 2.45. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.55.
On February 07, 2025, TD Cowen Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $45 to $60.
Jefferies Upgraded its Hold to Buy on January 21, 2025, whereas the target price for the stock was revised from $44 to $55.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 13 ’25 when Gangestad Nicholas C bought 2,000 shares for $43.97 per share. The transaction valued at 87,940 led to the insider holds 2,000 shares of the business.
Kalra Balkrishan sold 13,600 shares of G for $664,904 on Mar 13 ’25. The President and CEO now owns 310,246 shares after completing the transaction at $48.89 per share. On Mar 13 ’25, another insider, BALKRISHAN KALRA, who serves as the Officer of the company, bought 13,600 shares for $48.89 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, G now has a Market Capitalization of 7379682816 and an Enterprise Value of 8258430976. As of this moment, Genpact’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.36, and their Forward P/E ratio for the next fiscal year is 11.06. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.56. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.52 while its Price-to-Book (P/B) ratio in mrq is 3.01. Its current Enterprise Value per Revenue stands at 1.702 whereas that against EBITDA is 10.147.
Stock Price History:
The Beta on a monthly basis for G is 0.93, which has changed by 0.30246913 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, G has reached a high of $56.76, while it has fallen to a 52-week low of $32.18. The 50-Day Moving Average of the stock is -3.83%, while the 200-Day Moving Average is calculated to be -8.03%.
Shares Statistics:
The stock has traded on average 1.77M shares per day over the past 3-months and 1811370 shares per day over the last 10 days, according to various share statistics. A total of 174.87M shares are outstanding, with a floating share count of 160.50M. Insiders hold about 8.22% of the company’s shares, while institutions hold 94.53% stake in the company. Shares short for G as of 1752537600 were 6940107 with a Short Ratio of 3.93, compared to 1749772800 on 5930433. Therefore, it implies a Short% of Shares Outstanding of 6940107 and a Short% of Float of 4.5300003.
Dividends & Splits
In the trailing 12 months, G’s forward annual dividend rate was 0.628, compared to 0.64 this year. Against a Trailing Annual Dividend Yield of 0.014821809The stock’s 5-year Average Dividend Yield is 1.21.
Earnings Estimates
The market rating of Genpact Ltd (G) is currently shaped by the ongoing analysis conducted by 9.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.88, with high estimates of $0.9 and low estimates of $0.86.
Analysts are recommending an EPS of between $3.52 and $3.44 for the fiscal current year, implying an average EPS of $3.48. EPS for the following year is $3.82, with 10.0 analysts recommending between $3.92 and $3.66.
Revenue Estimates
8 analysts predict $1.23B in revenue for the current quarter. It ranges from a high estimate of $1.24B to a low estimate of $1.22B. As of the current estimate, Genpact Ltd’s year-ago sales were $1.18BFor the next quarter, 8 analysts are estimating revenue of $1.26B. There is a high estimate of $1.27B for the next quarter, whereas the lowest estimate is $1.23B.
A total of 10 analysts have provided revenue estimates for G’s current fiscal year. The highest revenue estimate was $5.01B, while the lowest revenue estimate was $4.93B, resulting in an average revenue estimate of $4.98B. In the same quarter a year ago, actual revenue was $4.77BBased on 10 analysts’ estimates, the company’s revenue will be $5.3B in the next fiscal year. The high estimate is $5.4B and the low estimate is $5.11B.
